Interestingly, assessment of the plasma of AD patients led to the finding that soluble TREM1 (sTREM1) levels were elevated, and concentrations of sTREM1 correlated to disease progression in AD patients (Jiang et al., 2019). This evidence concerns the gene TREM1 and Alzheimer disease.